A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/00 (2006.01) A61K 31/454 (2006.01) A61K 31/522 (2006.01) A61K 31/545 (2006.01) A61K 31/557 (2006.01) A61K 31/56 (2006.01) A61K 38/18 (2006.01) A61K 38/21 (2006.01) A61K 38/27 (2006.01)
Patent
CA 2504263
Methods of treating, preventing and/or managing macular degeneration are disclosed. Specific embodiments encompass the administration of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
L'invention concerne des méthodes de traitement, prévention et/ou contrôle de la dégénérescence maculaire. Des modes de réalisation spécifiques consistent à administrer une substance médicamenteuse d'inhibition sélective des cytokines ou un sel, solvate, hydrate, stéréoisomère, clathrate ou promédicament acceptables sur le plan pharmaceutique de ladite substance, seuls ou associés à un deuxième agent actif ou à une intervention chirurgicale. Elle concerne également des compositions pharmaceutiques, des formes galéniques unitaires et des trousses pouvant être mises en application dans ces méthodes.
Celgene Corporation
Smart & Biggar
LandOfFree
Methods of using and compositions comprising selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of using and compositions comprising selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using and compositions comprising selective... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1380461